...
首页> 外文期刊>International Journal of Bipolar Disorders >Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports
【24h】

Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports

机译:长期接受锂治疗的患者的甲状腺和肾脏肿瘤:锂诊所的病例系列,文献复习和国际药物警戒报告

获取原文
           

摘要

Background Cancer had never been considered as a relevant problem in patients treated with lithium until 2015, when a document published by the European Medicine Agency concluded that long-term use of lithium might induce renal tumors. A few months later, we observed the case of a woman treated with lithium for 18?years who was diagnosed with both thyroid and renal tumors. Methods This study aimed to investigate the correlation between lithium treatment and thyroid or renal tumors. We analyzed clinical records in our lithium clinic database, causes of death of patients who had been visited at least once at the lithium clinic, reports of lithium adverse reactions in the European and WHO pharmacovigilance databases, and published cases of thyroid and renal tumors in long-term lithium-treated patients. Results Of the 1871 lithium patients who had been visited at least once between 1980 and 2013, eight had been diagnosed with thyroid papillary carcinoma and two with clear-cell renal-cell carcinoma. No cases of thyroid cancer and only one case of renal tumor were the cause of death according to the 375 available death certificates. VigiAccess database contained a total of 29 and 14 cases of renal and thyroid tumors, respectively. EudraVigilance database contained 21 cases of renal and 8 of thyroid neoplasms. Literature search yielded 6 published cases of thyroid papillary carcinoma and 25 cases of various renal tumors. However, two population-based studies did not find any increased risks of cancer in patients exposed to lithium, whereas two nationwide studies did not find any excess of renal tumors. Conclusion So far it has not been possible epidemiologically to confirm an increased risk of thyroid or renal cancers associated with lithium. Such a conclusion is supported by the findings of low rates and mortalities of thyroid or renal cancers from the present lithium clinic data.
机译:背景技术直到2015年,欧洲医学机构发表的一份文件得出结论认为,长期使用锂可能会诱发肾肿瘤,直到用锂治疗的患者才被认为是相关问题。几个月后,我们观察到一名妇女接受锂治疗18年的案例,该患者被诊断出患有甲状腺和肾脏肿瘤。方法本研究旨在探讨锂治疗与甲状腺或肾脏肿瘤之间的相关性。我们分析了锂诊所数据库中的临床记录,在锂诊所至少拜访过一次的患者的死因,欧洲和WHO药物警戒数据库中锂不良反应的报告以及长期发表的甲状腺和肾脏肿瘤病例足月接受锂治疗的患者。结果在1980年至2013年期间至少接受过一次锂治疗的1871位锂患者中,有8位被诊断为甲状腺乳头状癌,另外2位被诊断为透明细胞肾细胞癌。根据375份死亡证明,没有甲状腺癌病例,只有1例肾肿瘤是死亡原因。 VigiAccess数据库分别包含总共29例和14例肾和甲状腺肿瘤。 EudraVigilance数据库包含21例肾脏病和8例甲状腺肿瘤。文献检索产生了6例已发表的甲状腺乳头状癌和25例各种肾肿瘤。但是,两项基于人群的研究并未发现接触锂的患者罹患癌症的风险增加,而两项全国性研究并未发现肾脏肿瘤过多。结论到目前为止,在流行病学上尚无法确定与锂有关的甲状腺癌或肾癌的风险增加。根据目前的锂临床数据,甲状腺癌或肾癌的低发病率和死亡率的发现支持了这一结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号